• Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

H1N1 Flu Poses Unique Risks for Patients With Diabetes


Both seasonal and H1N1 influenza pose a greater risk of severe illness and complications in patients with diabetes-and these infections can also wreak havoc with blood glucose levels.

Both H1N1 and seasonal influenza pose a greater risk of severe illness and complications in patients with diabetes. Moreover, these infections can wreak havoc with blood glucose levels.

About 12% of all persons and 19% of all adults hospitalized because of H1N1 influenza have had diabetes. One in four hospitalized patients with diabetes required intensive care unit management, said Anne Schuchat, MD, Director of CDC’s National Center for Immunization and Respiratory Diseases, at a recent press conference.

The CDC recommends that all persons with diabetes aged 6 months through 64 years receive the 2009 H1N1 influenza vaccine, and all those who are 6 months or older, including all persons aged 65 and older, should receive the seasonal influenza vaccine. The intranasal live attenuated vaccine is not recommended for persons with diabetes.

Persons with diabetes who have fever and cough or other influenza-like symptoms need to contact their health care provider, said Dr Schuchat. Those with suspected or confirmed 2009 H1N1 infection should be treated promptly with antiviral drugs (oseltamivir [Tamiflu] or zanamivir [Relenza]). “It’s not necessary to wait for influenza test results to come back,” she said. “It’s just important to start antiviral therapy promptly.”

Dr Schuchat also emphasized that patients with diabetes need to be vaccinated against pneumococcal infection. “Many with diabetes and other chronic conditions have not received the pneumococcal vaccine. As with seasonal influenza, we have seen pneumococcal pneumonia following H1N1 influenza.”

Related Videos
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Related Content
© 2024 MJH Life Sciences

All rights reserved.